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A lthough the adoption of radial access forpercutaneous coronary intervention (PCI) inthe United States was delayed as compared
with the rest of the world, there has been a recent ac-
celeration in the widespread utilization of this access
site for PCI. From 2007 to 2012, transradial PCI
increased from 1.0% to 16.2% of the PCI procedures
in the United States, and is further increasing (1,2).
Data demonstrating lower-access and nonaccess-site
bleeding associated with radial access, improved and
dedicated radial access equipment, and the wide
dissemination of radial-speciﬁc training have all
contributed to the shift in access site strategy (3).
Transradial PCI in acute coronary syndrome (ACS)
and ST-segment elevation myocardial infarction
(STEMI) patients also appears to be associated with
lower mortality, although no unequivocal mecha-
nistic link for this mortality reduction has been iden-
tiﬁed (3,4). Nevertheless, the negative long-term
adverse effects of bleeding after PCI are well recog-
nized, and the European guidelines for PCI have
weighed in on the subject, giving radial access a
Class I indication for ACS patients undergoing PCI (5).
In this issue of JACC: Cardiovascular Interventions,
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Speakers Bureau for AstraZeneca.study of rescue PCI from the American College of
Cardiology National Cardiovascular Data Registry’sCathPCI Registry. Over 4 years (2009 to 2013), 9,494
STEMI patients underwent rescue PCI after failed
ﬁbrinolytic therapy; amazingly, only 14.2% of these
patients were treated transradially, whereas 85.8%
had transfemoral access. The transradial patients
were slightly younger, with lower prevalence of hy-
pertension, dyslipidemia, chronic lung disease, or
history of coronary artery bypass graft surgery.
Fluoroscopy time was slightly longer, thienopyridine
and glycoprotein inhibitor use were comparable, and
the use of unfractionated heparin was higher in the
transradial group. Successful treatment of the culprit
lesion was high and similar with both strategies
(96.1% radial and 94.7% femoral; p ¼ 0.06).
As in multiple previous studies (3,7–10), in an un-
adjusted analysis, lower access site bleeding (0.2%
radial vs. 1.1% femoral; p ¼ 0.001), overall bleeding
(6.9% radial vs. 12% femoral; p < 0.0001), blood
transfusion requirement (1.1% radial vs. 2.8%
femoral; p ¼ 0.0003), and a trend favoring mortality
reduction (1.7% radial and 2.6% femoral; p ¼ 0.05)
were observed with radial access. However, inverse
probability of treatment weighting–adjusted analysis
did not reveal a difference in mortality (odds ratio
[OR]: 0.81; 95% conﬁdence interval [CI]: 0.53 to 1.25;
p ¼ 0.35), but radial access remained associated
with lower bleeding (OR: 0.67; 95% CI: 0.52 to 0.87;
p ¼ 0.003). Importantly, using gastrointestinal (GI)
bleeding as a falsiﬁcation endpoint, lower GI bleeding
(OR: 0.23; 95% CI: 0.05 to 0.98; p ¼ 0.05) was
observed in the transradial group. As arterial access
site should not have an effect on GI bleeding, this
“negative control” ﬁnding suggests that confounders
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1878that cannot be assessed from the data collected in the
CathPCI Registry exist, and potentially, patients with
greater comorbidities or at higher risk of bleeding are
being treated with femoral access.
The investigators should be congratulated for
conducting the largest study of rescue PCI, and it is
remarkable that the use of radial access for rescue PCI
is <15% in contemporary interventional practice in
the United States. The study includes a broad patient
population, only excluding those requiring hemody-
namic support, receiving chronic hemodialysis, un-
dergoing in-hospital coronary artery bypass graft
surgery or multiple PCI procedures, or having
received ﬁbrinolytic therapy more than 72 h before
catheterization. Having just received ﬁbrinolytic
therapy and failing reperfusion (median time of
ﬁbrinolytic therapy to cardiac catheterization: 189
min), these patients would be at high risk for bleeding
especially if bailout glycoprotein IIb/IIIa inhibitors
were subsequently required. The investigators also
report the presence of a “risk-treatment paradox,”
with the patients at the lowest risk of bleeding among
the rescue PCI cohort being treated transradially. The
existence of a difference in the baseline risk of
bleeding in the transradial and transfemoral groups
was suggested by the falsiﬁcation endpoint of GI
bleeding (0.2% radial vs. 0.9% femoral; p ¼ 0.006)
and conﬁrmed by an elegant analysis evaluating the
pre-procedural bleeding risk proﬁle of the 2 groups.
Patients who underwent transfemoral rescue PCI
were, in fact, at a higher risk of bleeding (10.2  8.2%
radial vs. 12.0  8.5% femoral; p < 0.0001), and as
previously reported (11), this study is another
example of the failure to adequately utilize radial
access as a bleeding avoidance strategy in the
highest-risk patients.
Furthermore, as an access strategy, the radial
artery remains scarcely utilized in STEMI patients (1).
Despite extensive attention to the subject over the
past decade, in 80% of the hospitals in the United
States, radial access is still used in <10% of PCI pro-
cedures (2). Multiple explanations may exist for the
limited utilization of radial access for rescue PCI
patients, a group that is at among the highest risk of
bleeding. These include inadequate training with the
technique, especially in low-volume centers and
amongst low-volume operators; perceived ease of
femoral access in the more critically ill patients;
consideration of hemodynamic support if subse-
quently required; or underappreciation of bleeding as
an independent signiﬁcant adverse event. The cur-
rent analysis, especially with the negative control of a
GI bleed endpoint, suggests that as patients with a
greater number of comorbidities are being treated viafemoral access, reduction in nonaccess-site bleeding
and mortality associated with the radial access in
prior observational studies might also be a result of
confounding variables that are impossible to control
for in propensity-matched or multivariable analyses.
Randomized trials have yielded conﬂicting results on
the subject, although an updated meta-analysis,
including the large MATRIX Access (Minimizing
Adverse Haemorrhagic Events by TRansradial Access
Site and Systemic Implementation of angioX) trial,
supports the hypothesis that there is a mortality
reduction with transradial PCI in ACS patients (3).
Although the data regarding mortality reduction
with radial access is controversial due to the lack of a
clear mechanistic link, especially in elective PCI pa-
tients, the reduction in major and minor access site
bleeding is uncontested. However, the equivocal
message on mortality reduction with radial access
for PCI might have contributed to a slower adoption
for this approach by the majority of practicing
interventionalists.
A surprising observation from the current analysis
is the relatively low mortality for rescue PCI patients.
This might represent the improved contemporary
PCI practice, better pharmacotherapy, or perhaps
the relatively short time period between ﬁbrinolytic
therapy administration and rescue PCI. It could also
be due to the exclusion of the critically ill patients
who required hemodynamic support or in-hospital
coronary artery bypass graft/multiple PCI proce-
dures from the analysis. This could also have
contributed to the inability to demonstrate a mortal-
ity difference with the radial access approach.
Despite the increase in use of the radial access for
PCI overall, it appears that the adoption of radial PCI
for acute STEMI patients remains limited in the
United States (1,2). The explanation may lie with the
concern for meeting door-to-balloon time goals and
the possible delay in reperfusion as a result of
operator inexperience with radial PCI; yet, the un-
derutilization for rescue PCI after failed ﬁbrinolytic
therapy is puzzling. The underlying reasons for this
cannot be ascertained from the current analysis, and
future investigation should focus on identifying
them. This could then lead to the implementation of
transradial PCI and other bleeding avoidance stra-
tegies for patients at the highest risk of bleeding
after PCI.
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